Danaher Co. (NYSE:DHR) Receives Consensus Recommendation of "Moderate Buy" From Analysts
Danaher Co. (NYSE:DHR) Receives Consensus Recommendation of "Moderate Buy" From Analysts
Danaher Co. (NYSE:DHR – Get Rating) has received a consensus recommendation of "Moderate Buy" from the fourteen research firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $310.17.
据市场评级公司报道，Danaher Co.(纽约证券交易所股票代码：DHR-GET Rating)已经收到了14家研究公司的一致建议，即“适度买入”。两名股票研究分析师对该股的评级为持有建议，十名分析师给该公司指定了买入建议。在去年更新了对该股覆盖范围的分析师中，平均12个月的价格目标是310.17美元。
A number of equities analysts recently commented on the company. StockNews.com downgraded Danaher from a "strong-buy" rating to a "buy" rating in a report on Thursday. Sanford C. Bernstein started coverage on Danaher in a report on Tuesday, August 16th. They set an "outperform" rating and a $340.00 target price for the company. Robert W. Baird decreased their price objective on Danaher from $325.00 to $315.00 and set an "outperform" rating for the company in a report on Friday, October 21st. Royal Bank of Canada reduced their price target on Danaher from $318.00 to $302.00 and set an "outperform" rating for the company in a report on Friday, October 21st. Finally, JPMorgan Chase & Co. reduced their price target on Danaher from $350.00 to $315.00 and set an "overweight" rating for the company in a report on Friday, October 21st.
一些股票分析师最近对该公司发表了评论。StockNews.com在周四的一份报告中将Danaher的评级从“强势买入”下调至“买入”.桑福德·C·伯恩斯坦在8月16日星期二的一份报告中开始了对丹纳赫的报道。他们为该公司设定了“跑赢大盘”的评级和340.00美元的目标价。罗伯特·W·贝尔德将他们对Danaher的目标价从325.00美元下调至315.00美元，并在10月21日星期五的一份报告中为该公司设定了“跑赢大盘”的评级。加拿大皇家银行将他们对Danaher的目标价从318.00美元下调至302.00美元，并在10月21日(周五)的一份报告中为该公司设定了“跑赢大盘”的评级。最终，摩根大通将丹纳赫的目标价从350.00美元下调至315.00美元，并在10月21日星期五的一份报告中对该公司设定了“增持”评级。
Danaher Stock Down 0.9 %
Danaher股价下跌0.9%
Shares of DHR opened at $269.34 on Friday. The firm has a market cap of $196.07 billion, a P/E ratio of 29.76, a P/E/G ratio of 2.12 and a beta of 0.83. The stock has a 50 day simple moving average of $260.68 and a two-hundred day simple moving average of $266.38. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.78 and a quick ratio of 1.38. Danaher has a 1 year low of $233.71 and a 1 year high of $331.23.
上周五，DHR的股价开盘报269.34美元。该公司市值为1960.7亿美元，市盈率为29.76倍，市盈率为2.12倍，贝塔系数为0.83。该股的50日简单移动均线切入位为260.68美元，200日简单移动均线切入位为266.38美元。该公司的债务权益比为0.41，流动比率为1.78，速动比率为1.38。丹纳赫的一年低点为233.71美元，一年高位为331.23美元。
Danaher Dividend Announcement
丹纳赫宣布分红
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Thursday, December 29th. Danaher's payout ratio is 11.05%.
该公司最近还披露了季度股息，将于1月27日(星期五)支付。12月30日(星期五)登记在册的股东将获得0.25美元的股息。这意味着年化股息为1.00美元，收益率为0.37%。除股息日期为12月29日(星期四)。Danaher的派息率为11.05%。
Insiders Place Their Bets
内部人士下注
In other Danaher news, CFO Matthew Mcgrew sold 18,935 shares of Danaher stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $274.72, for a total value of $5,201,823.20. Following the sale, the chief financial officer now owns 29,634 shares of the company's stock, valued at approximately $8,141,052.48. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Matthew Mcgrew sold 18,935 shares of the business's stock in a transaction on Friday, November 11th. The stock was sold at an average price of $274.72, for a total transaction of $5,201,823.20. Following the completion of the transaction, the chief financial officer now owns 29,634 shares in the company, valued at approximately $8,141,052.48. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Joakim Weidemanis sold 9,508 shares of the business's stock in a transaction on Monday, November 28th. The shares were sold at an average price of $266.60, for a total value of $2,534,832.80. Following the transaction, the executive vice president now owns 71,498 shares of the company's stock, valued at approximately $19,061,366.80. The disclosure for this sale can be found here. Insiders have sold a total of 39,038 shares of company stock valued at $10,550,749 in the last quarter. 11.20% of the stock is currently owned by insiders.
在Danaher的其他新闻中，CFO Matthew McGrew在11月11日星期五的一笔交易中出售了18,935股Danaher股票。这只股票的平均售价为274.72美元，总价值为5201,823.20美元。出售后，首席财务官现在拥有29,634股公司股票，价值约8,141,052.48美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。在相关新闻中，首席财务官马修·麦格鲁在11月11日星期五的一次交易中出售了18,935股该公司的股票。该股以274.72美元的平均价格出售，总成交金额为5201,823.20美元。交易完成后，首席财务官现在拥有该公司29,634股，价值约8,141,052.48美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。此外，执行副总裁Joakim Weidemanis在11月28日星期一的一次交易中出售了9508股该公司的股票。这些股票的平均价格为266.60美元，总价值为2,534,832.80美元。交易完成后，执行副总裁总裁现在持有该公司71,498股股票，价值约19,061,366.80美元。关于这次销售的披露可以找到这里。上个季度，内部人士总共出售了39,038股公司股票，价值10,550,749美元。该公司11.20%的股份目前由内部人士持有。
Institutional Inflows and Outflows
机构资金流入和流出
Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in Danaher by 1.9% during the 3rd quarter. Vanguard Group Inc. now owns 53,690,131 shares of the conglomerate's stock valued at $13,867,623,000 after purchasing an additional 995,501 shares during the last quarter. Northern Trust Corp boosted its position in Danaher by 0.8% during the second quarter. Northern Trust Corp now owns 8,061,833 shares of the conglomerate's stock worth $2,043,836,000 after purchasing an additional 65,824 shares in the last quarter. Legal & General Group Plc boosted its position in Danaher by 6.4% during the second quarter. Legal & General Group Plc now owns 4,656,373 shares of the conglomerate's stock worth $1,180,485,000 after purchasing an additional 279,432 shares in the last quarter. Amundi boosted its position in Danaher by 10.2% during the second quarter. Amundi now owns 4,649,220 shares of the conglomerate's stock worth $1,157,183,000 after purchasing an additional 431,694 shares in the last quarter. Finally, Parnassus Investments LLC boosted its position in Danaher by 3.0% during the second quarter. Parnassus Investments LLC now owns 4,622,607 shares of the conglomerate's stock worth $1,171,923,000 after purchasing an additional 135,251 shares in the last quarter. 77.27% of the stock is owned by institutional investors and hedge funds.
对冲基金最近增持或减持了该业务的股份。先锋集团(Vanguard Group Inc.)第三季度增持丹纳赫股份1.9%。先锋集团目前持有53,690,131股该集团股票，价值13,867,623,000美元，上个季度又购买了995,501股。北方信托公司在第二季度将其在Danaher的头寸增加了0.8%。北方信托公司目前持有该集团8,061,833股股票，价值2,043,836,000美元，此前该公司在上个季度又购买了65,824股。Legal&General Group Plc在第二季度将其在Danaher的头寸增加了6.4%。Legal&General Group Plc现在拥有该集团4,656,373股股票，价值1,180,485,000美元，上个季度又购买了279,432股。Amundi在第二季度将其在Danaher的头寸增加了10.2%。Amundi现在持有该集团4,649,220股股票，价值1,157,183,000美元，上个季度又购买了431,694股。最后，Parnassus Investments LLC在第二季度将其在Danaher的头寸增加了3.0%。Parnassus Investments LLC现在拥有该集团4,622,607股股票，价值1,171,923,000美元，上个季度又购买了135,251股。77.27%的股票由机构投资者和对冲基金持有。
About Danaher
关于丹纳赫
(Get Rating)
(获取评级)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
丹纳赫公司在全球设计、制造和营销专业、医疗、工业和商业产品和服务。该公司通过三个部门运营：生命科学、诊断和环境与应用解决方案。生命科学部门提供质谱仪；流式细胞术、基因组学、实验室自动化、离心法、颗粒计数和表征；显微镜；基因组耗材；以及基因和细胞治疗。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- MarketBeat: Week in Review 12/05 – 12/09
- There Is Fundamental Value In Broadcom, And It Yields 3.35%
- Costco vs Amazon: an end of the year showdown
- Discount Retailers Could Make Good Bargain Stocks
- Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
- 免费获取StockNews.com关于Danaher的研究报告(DHR)
- MarketBeat：回顾一周12/05-12/09
- 博通有基本面价值，收益率为3.35%
- 好市多VS亚马逊：年底摊牌
- 折扣零售商可以做好的便宜货
- 辉瑞、强生能否继续跑赢该指数？
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
接受《丹纳赫日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Danaher和相关公司的最新新闻和分析师评级的每日简要摘要。